PMID- 20961772 OWN - NLM STAT- MEDLINE DCOM- 20120112 LR - 20220316 IS - 1873-734X (Electronic) IS - 1010-7940 (Linking) VI - 40 IP - 2 DP - 2011 Aug TI - Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. PG - 282-6 LID - 10.1016/j.ejcts.2010.09.005 [doi] AB - OBJECTIVE: To compare the efficacy, safety, and outcome of thoracoscopic talc poudrage (TTP) versus povidone-iodine pleurodesis (PIP) through a thoracostomy tube as a palliative treatment of pleural effusion due to metastatic breast carcinoma (MBC). METHODS: A total of 42 MBC patients were prospectively enrolled in a randomized controlled trial. Twenty-two patients received TTP (group A), whereas 20 patients (group B) underwent pleurodesis by instilling povidone-iodine through a thoracostomy tube, as a bedside procedure. RESULTS: The mean age was 48.2 +/- 9.9 (range: 29-64) years and 50.2 +/- 7 (range: 32-62) years for groups A and B, respectively (p=ns). At presentation, all patients had moderate to severe dyspnea, New York Heart Association (NYHA)>II and Medical Research Council (MRC) dyspnea scale 3-5. Morbidity in both groups was low. Post-procedure analgesic requirements due to severe pleuritic chest pain were higher in group A (18% vs 0%, p=0.2). Four patients in group A (18%) and one in group B (5%) were febrile (>38 degrees C) within 48 h of the procedure. Both groups achieved good symptom control, with improvement in MRC dyspnea scale (1-3). There were no in-hospital deaths. Post-procedure hospital stay was lower in group B (p=0.009). The mean progression-free interval was 6.6 (range 3-15) months. At follow-up (mean: 22.6 (range: 8-48) months), recurrence of significant pleural effusion requiring intervention was noted in two and three patients in group A and group B, respectively (p=ns). CONCLUSION: Povidone-iodine can be considered as a good alternative to TTP to ensure effective pleurodesis for patients with malignant pleural effusion due to MBC. The drug is available, cost effective and safe, can be given through a thoracostomy tube and can be repeated if necessary. CI - Copyright (c) 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved. FAU - Mohsen, Tarek A AU - Mohsen TA AD - Department of Cardiothoracic Surgery, Kasr El Aini Hospital, Cairo University Hospitals, El Manial, Egypt. FAU - Zeid, Amany A Abou AU - Zeid AA FAU - Meshref, Mohamed AU - Meshref M FAU - Tawfeek, Nehad AU - Tawfeek N FAU - Redmond, Karen AU - Redmond K FAU - Ananiadou, Olga G AU - Ananiadou OG FAU - Haj-Yahia, Saleem AU - Haj-Yahia S LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20101018 PL - Germany TA - Eur J Cardiothorac Surg JT - European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery JID - 8804069 RN - 14807-96-6 (Talc) RN - 85H0HZU99M (Povidone-Iodine) SB - IM CIN - Eur J Cardiothorac Surg. 2011 Aug;40(2):277-9. PMID: 21194963 CIN - Eur J Cardiothorac Surg. 2012 May;41(5):1209. PMID: 22219431 MH - Adult MH - Anesthesia, General/methods MH - Breast Neoplasms/complications MH - Dyspnea/etiology MH - Female MH - Humans MH - Insufflation/methods MH - Middle Aged MH - Palliative Care/methods MH - Pleural Effusion, Malignant/complications/*therapy MH - Pleurodesis/*methods MH - Povidone-Iodine/*administration & dosage MH - Prospective Studies MH - Recurrence MH - Talc/*therapeutic use MH - Thoracic Surgery, Video-Assisted/methods MH - Treatment Outcome EDAT- 2010/10/22 06:00 MHDA- 2012/01/13 06:00 CRDT- 2010/10/22 06:00 PHST- 2010/01/10 00:00 [received] PHST- 2010/09/01 00:00 [revised] PHST- 2010/09/05 00:00 [accepted] PHST- 2010/10/22 06:00 [entrez] PHST- 2010/10/22 06:00 [pubmed] PHST- 2012/01/13 06:00 [medline] AID - S1010-7940(10)00763-3 [pii] AID - 10.1016/j.ejcts.2010.09.005 [doi] PST - ppublish SO - Eur J Cardiothorac Surg. 2011 Aug;40(2):282-6. doi: 10.1016/j.ejcts.2010.09.005. Epub 2010 Oct 18.